Literature DB >> 15215150

Pharmacokinetics of oral valganciclovir and intravenous ganciclovir administered to prevent cytomegalovirus disease in an adult patient receiving small-intestine transplantation.

Jesús Fortún Abete, Pilar Martín-Dávila, S Moreno, Yolanda Quijano, Emilio de Vicente, Leonor Pou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15215150      PMCID： PMC434162          DOI： 10.1128/AAC.48.7.2782-2783.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  3 in total

1.  Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients.

Authors:  M D Pescovitz; J Rabkin; R M Merion; C V Paya; J Pirsch; R B Freeman; J O'Grady; C Robinson; Z To; K Wren; L Banken; W Buhles; F Brown
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects.

Authors:  D Jung; A Dorr
Journal:  J Clin Pharmacol       Date:  1999-08       Impact factor: 3.126

3.  Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.

Authors:  R Mañez; S Kusne; M Green; K Abu-Elmagd; W Irish; J Reyes; H Furukawa; A Tzakis; J J Fung; S Todo
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939
  3 in total
  3 in total

1.  Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgery.

Authors:  Deric M Park; Dhvani D Shah; Merrill J Egorin; Jan H Beumer
Journal:  J Neurooncol       Date:  2009-01-06       Impact factor: 4.130

Review 2.  Management of cytomegalovirus corneal endotheliitis.

Authors:  Angela H Y Wong; Wee Nie Kua; Alvin L Young; Kelvin H Wan
Journal:  Eye Vis (Lond)       Date:  2021-01-14

Review 3.  HCMV Antivirals and Strategies to Target the Latent Reservoir.

Authors:  Marianne R Perera; Mark R Wills; John H Sinclair
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.818
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.